Zeaxanthin.

Zeaxanthin is fat-soluble and has to be carried in mixed micelles and then chylomicrons to be absorbed, which only happens when dietary fat is present in the gut. Taking it alongside a fat source such as fish oil supplies the lipid its uptake depends on.

Zeaxanthin and vitamin E both partition into the fatty core of membranes and lipoproteins, where the carotenoid quenches singlet oxygen and vitamin E stops the chain reaction of lipid oxidation. Acting in the same lipid compartment by different routes, they extend each other's antioxidant reach.

Carotenoids compete for limited space in mixed micelles and for the same intestinal uptake transporter, and beta carotene is the strongest competitor of the group. High beta carotene alongside zeaxanthin lowers how much zeaxanthin is absorbed.

Zeaxanthin is fat soluble and needs lipid present to form the mixed micelles that carry it across the intestinal wall, so absorption from a fat-free dose is poor. An oil base, or a meal containing fat, is the practical version of this.

Ascorbate regenerates the tocopherol radical at the membrane surface, which in turn spares carotenoids from being consumed as they quench singlet oxygen in the retina. The network keeps zeaxanthin intact rather than sacrificed.

Zinc is concentrated in the retina and pigment epithelium where it is a cofactor for retinol dehydrogenase and for superoxide dismutase. It supports the enzymatic side of retinal maintenance that a pigment filter does not cover.

Sustained higher-dose zinc induces intestinal metallothionein, which binds copper preferentially and lowers copper absorption. Eye formulas built around zeaxanthin and zinc include copper as standard practice to keep the two minerals in balance.

Plant sterols compete with carotenoids for incorporation into mixed micelles, the same mechanism by which they lower cholesterol absorption. Taken in the same dose they measurably reduce carotenoid uptake, so the doses belong apart.

Psyllium forms a viscous gel that slows lipid mixing and binds fat-soluble compounds in the gut lumen, lowering carotenoid absorption from that meal. Separating the two by a couple of hours avoids the loss.

Pectin raises luminal viscosity and binds bile acids, both of which reduce the micellar solubilisation carotenoid uptake depends on. Carotenoid absorption drops when pectin is taken in the same dose.

Astaxanthin spans the lipid bilayer with polar groups on both faces, quenching radicals at the surface and in the core, while zeaxanthin sits transmembrane in the macula as a blue-light filter. They occupy different roles, though both compete for the same absorption route and should be spaced or co-dosed with fat.

Bilberry anthocyanins are reported to support rhodopsin regeneration in the rods and microvascular integrity in the retina, neither of which is what a macular pigment does. Zeaxanthin filters short-wavelength light at the macula, so the two cover distinct parts of normal visual function.

Preformed retinol and carotenoids share intestinal uptake and lymphatic transport, and high retinol intake downregulates the cleavage enzyme that processes provitamin carotenoids. Zeaxanthin is not a provitamin A carotenoid, so it contributes pigment while vitamin A covers the rhodopsin cycle, but the absorption route is shared and doses compete.

Meso-zeaxanthin is a stereoisomer that the retina forms from lutein rather than one obtained in quantity from ordinary food, and together with zeaxanthin it makes up the central macular pigment. The randomised trial in this set that measured macular pigment used lutein, zeaxanthin and meso-zeaxanthin as one formula. Macular pigment optical density is a measured marker of pigment, not itself a clinical outcome.

Zeaxanthin is fat soluble and needs dietary lipid to form the mixed micelles that carry it across the gut wall, and DHA is also the dominant fatty acid in photoreceptor membranes. The paper in this set that looked at omega-3 supplements alongside these carotenoids examined exactly this uptake question. Read its findings as bioavailability and oxidative markers rather than as vision outcomes.

Long-chain omega-3 fatty acids change the lipid composition of the micelles and lipoproteins that carry xanthophylls, which is the interaction the bioavailability paper in this set set out to measure. EPA travels that same route as DHA. The outcome measured was carotenoid availability, a marker.

Phospholipids are a required component of the mixed micelles that solubilise carotenoids in the small intestine, and lecithin supplies them. This is why zeaxanthin taken with a fat-free meal is absorbed less completely than the same dose with food. The mechanism is settled. The size of the gain depends on the rest of the meal.

Phosphatidylcholine is the main phospholipid in lecithin and a standard emulsifier in carotenoid beadlets and emulsions for the same reason: it helps disperse a lipophilic pigment into an absorbable phase. The effect is on delivery, not on what zeaxanthin does once absorbed.

Zeaxanthin quenches singlet oxygen in the lipid phase of retinal membranes, while glutathione operates in the aqueous phase and regenerates other antioxidants. The two cover different compartments of the same chemistry. Antioxidant capacity measured in a tube or in plasma is a marker, not an outcome.

Alpha-lipoic acid is active in both water-soluble and lipid environments and participates in regenerating other antioxidants, so it sits upstream of the lipid-phase work zeaxanthin does. No combination trial appears in this candidate set. The rationale is network chemistry only.

Riboflavin becomes FAD, the cofactor glutathione reductase needs to keep glutathione in its reduced form, which is what keeps the wider antioxidant network turning over around a lipid-phase quencher such as zeaxanthin. This is cofactor dependency, established at the enzyme level. It says nothing about a measured combined effect on vision.

Glutathione peroxidases carry selenium at their active site and clear lipid hydroperoxides, the products left behind when membrane lipids are attacked. Zeaxanthin works earlier in that sequence by quenching the excited oxygen species. Different steps, one pathway.

All dietary carotenoids share the same micellar uptake step and the same lipoprotein carriers out of the intestine, so a large dose of one lowers the measured plasma appearance of another. Lycopene is a hydrocarbon carotenoid and competes with the xanthophylls on that route. This is a bioavailability interaction, not a reason to avoid either.

Viscous soluble fibres thicken intestinal contents and bind bile acids, both of which reduce how efficiently fat-soluble pigments are taken up. Guar gum is one of the more viscous of them. Separating the two doses in the day is the practical response.

Glucomannan forms a high-viscosity gel in the gut, which slows micelle formation and lowers the fraction of a fat-soluble carotenoid that gets absorbed. The mechanism is the same one that makes it useful for satiety. Timing the two apart addresses it.

Taurine is among the most abundant free amino acids in the retina and contributes to photoreceptor membrane stability, a different job from the blue-light absorption and singlet-oxygen quenching zeaxanthin performs. Nothing in this candidate set tested them together. The pairing is anatomical logic.

Lutein and zeaxanthin are the two carotenoids the retina concentrates into macular pigment, zeaxanthin at the centre and lutein around it. They arrive in the diet together, from the same leafy greens and egg yolk, and the body deposits them side by side. A formula that carries one without the other supplies half of the pigment.